A clinical trial of XEN901

Trial Profile

A clinical trial of XEN901

Planning
Phase of Trial: Phase I

Latest Information Update: 11 Mar 2017

At a glance

  • Drugs XEN 901 (Primary)
  • Indications Epilepsy
  • Focus Adverse reactions
  • Most Recent Events

    • 11 Mar 2017 New trial record
    • 08 Mar 2017 The company expects to file an IND, or IND equivalent, application in the fourth quarter of 2017, according to a Xenon Pharmaceuticals media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top